Frost Sullivan AI biologics and supply resilience redefine pharma growth through 2031
LONDON, June 11, 2026 /PRNewswire/ — Frost & Sullivan’s latest analysis, Growth Opportunities in Global Pharmaceutical Industry, 2026, finds that the pharmaceutical industry is entering...
